Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.
Gallot G, Vollant S, Saïagh S, Clémenceau B, Vivien R, Cerato E, Bignon JD, Ferrand C, Jaccard A, Vigouroux S, Choquet S, Dalle JH, Frachon I, Bruno B, Mothy M, Mechinaud F, Leblond V, Milpied N, Vié H. Gallot G, et al. Among authors: saiagh s. J Immunother. 2014 Apr;37(3):170-9. doi: 10.1097/CJI.0000000000000031. J Immunother. 2014. PMID: 24598452 Clinical Trial.
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients.
Dréno B, Khammari A, Fortun A, Vignard V, Saiagh S, Beauvais T, Jouand N, Bercegay S, Simon S, Lang F, Labarrière N. Dréno B, et al. Among authors: saiagh s. Cancer Immunol Immunother. 2021 Oct;70(10):3015-3030. doi: 10.1007/s00262-021-02961-0. Epub 2021 Jun 12. Cancer Immunol Immunother. 2021. PMID: 34120214 Free PMC article. Clinical Trial.
[Can academic structures improve access to CAR-T cells?].
Le Guen C, Grain A, Le Calvez B, Saiagh S, Vrignaud F, Eveillard M, Clémenceau B, Zahar MB. Le Guen C, et al. Among authors: saiagh s. Bull Cancer. 2024 Jan;111(1):62-72. doi: 10.1016/j.bulcan.2023.10.005. Epub 2023 Nov 28. Bull Cancer. 2024. PMID: 38030508 Review. French.
Tissue biomarkers in melanoma patients treated with TIL.
Knol AC, Nguyen JM, Pandolfino MC, Quéreux G, Brocard A, Peuvrel L, Saint-Jean M, Saiagh S, Khammari A, Dréno B. Knol AC, et al. Among authors: saiagh s. PLoS One. 2012;7(12):e48729. doi: 10.1371/journal.pone.0048729. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284620 Free PMC article.
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.
Saint-Jean M, Knol AC, Volteau C, Quéreux G, Peuvrel L, Brocard A, Pandolfino MC, Saiagh S, Nguyen JM, Bedane C, Basset-Seguin N, Khammari A, Dréno B. Saint-Jean M, et al. Among authors: saiagh s. J Immunol Res. 2018 Mar 19;2018:3530148. doi: 10.1155/2018/3530148. eCollection 2018. J Immunol Res. 2018. PMID: 29750176 Free PMC article.
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.
Khammari A, Nguyen JM, Leccia MT, Guillot B, Saiagh S, Pandolfino MC, Knol AC, Quéreux G, Chiffolettau A, Labarrière N, Dréno B. Khammari A, et al. Among authors: saiagh s. Cancer Immunol Immunother. 2020 Aug;69(8):1663-1672. doi: 10.1007/s00262-020-02572-1. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306076 Free PMC article. Clinical Trial.
29 results